ROCHESTER, N.Y., Feb. 1, 2010 (GLOBE NEWSWIRE) -- NaturalNano, Inc. (Pink Sheets:NNAN) (Frankfurt:N3N) announced today that Fiabila S.A., a world leader in private label nail polish manufacturing, has committed to the continued use of NaturalNano’s environmentally friendly Halloysite Natural Tubules (HNT™) technology in its nail polish products.
“Utilization of our HNT™ technology provides increased durability and performance in their nail polish products,” said James Wemett, acting CEO & president of NaturalNano. “We are excited about the alliance we’ve formed and our relationship with Fiabila, one of the world’s leading private manufacturers of nail enamels. This represents a long term revenue opportunity for NaturalNano and we are very pleased with the technical and commercial success shown to date in the Fiabila nail polish product.”
Pierre Miasnik, President of Fiabila commented, “NaturalNano’s technology provides Fiabila the opportunity to offer products with natural ingredients and the chance to maintain an edge in the market place.”
NaturalNano has a long term exclusive supply agreement and license with Fiabila for nail polish and nail-care products. Products manufactured by Fiabila with HNT™ technology are available at most major retail stores including Wal-Mart, CVS, and Walgreens.
About NaturalNano, Inc.
NaturalNano, Inc. (Pink Sheets:NNAN) (Frankfurt:N3N) is a materials science company focused on developing and commercializing advanced nanocomposites. The Company is focused on additive technologies and processes, including their proprietary Pleximer that adds value to industrial polymers, plastics and composites. NaturalNano holds and licenses 24 patents and applications, as well as proprietary know-how for extraction and separation processes, compositions, and derivatives of Halloysite. http://www.naturalnano.com/">www.naturalnano.com
Cautionary Statement Regarding Forward-Looking Statements: Contains forward-looking statements regarding future events and future performance that involve risks and uncertainties that could materially affect actual results. This information is qualified in its entirety by cautionary statements and risk factors disclosure contained in certain of NaturalNano's filings with the Securities and Exchange Commission. The most recent annual reports on Form 10-K and quarterly reports on Form 10-Q filed by NaturalNano provide information about these factors, which may be revised or supplemented in future reports to the SEC on those forms or on Form 8-K. We caution investors not to place undue reliance on forward-looking statements, and we do not undertake any obligation to update or otherwise revise any forward-looking statements, whether as a result of new information, future events, or other such factors that affect the subject of these statements, except where expressly required by law.